<DOC>
	<DOCNO>NCT00208208</DOCNO>
	<brief_summary>Atypical antipsychotic show promise treatment depression anxiety , prominent symptom PTSD . The profile atypical antipsychotic , ziprasidone ( Geodon ) , suggest possible anxiolytic antidepressant property . This research ass potential effectiveness Geodon civilian men woman suffer severe PTSD . Response ziprasidone placebo measure Clinician Administered PTSD Scale ( CAPS ) Treatment Outcomes PTSD Scale ( TOP-8 ) .</brief_summary>
	<brief_title>Geodon ( Ziprasidone ) Posttraumatic Stress Disorder</brief_title>
	<detailed_description>PTSD common disorder 10 % lifetime prevalence among Americans . The major cause PTSD sexual assault , accident , disaster Despite public health burden , two drug , sertraline ( Zoloft ) paroxetine ( Paxil ) , approve FDA treatment PTSD . New option treatment PTSD much need . Approximately half patient PTSD respond Zoloft Paxil . Many patient experience psychotic symptom PTSD , may respond treatment Zoloft Paxil . Though classify anxiety disorder DSM-IV , PTSD accompany psychotic symptom almost half patient ( Butler et al 1996 ; Hamner et al 1999 , Lindley et al 2000 ) . Also , PTSD extensive comorbidity major depressive disorder ( Davis et al 2000 ) . While Geodon approve FDA United States treatment psychosis , evaluate treatment PTSD . A clinical trial Geodon PTSD help delineate potential antidepressant spectrum efficacy Geodon well anxiolytic profile .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Men &amp; woman DSMIV clinical diagnosis PTSD able attend weekly clinic appointment Age 1964 , pregnant either sterile use medically acceptable method birth control A willingness ability provide competent sign informed consent A level understand sufficient perform test examination require protocol ( include fluency spoken English ) Any diagnosis schizophrenia bipolar I disorder , active substance dependence Unstable general medical condition serious illness ( e.g.. death hospitalization anticipate within one year ) , poor kidney function , liver function ( define lab value â‰¥ three time upper limit laboratory normal ) seizure disorder exception childhood seizure disorder . Subjects prior nonresponse Geodon treatment PTSD adequate trial Enrollment study drug within last 30 day . Current pharmacotherapy permit , provide medication dose stable past 90 day . Pregnancy nurse Any subject judge clinically serious suicidal risk opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>Posttraumatic Stress Disorder</keyword>
	<keyword>Post-traumatic Stress Disorder</keyword>
	<keyword>PTSD</keyword>
	<keyword>Geodon</keyword>
	<keyword>Ziprasidone</keyword>
</DOC>